The findings appear in the journal Cell Stem Cell.
Patients have symptoms for persistent loss of both vision and movement.
“Since this is a natural protein, we are unconcerned.”
“This provides us with a much better understanding of clinical relevance of this protein and our integrated approach across many animal models, and is a step toward translating the aging biology hypothesis into novel therapies for PD,” said author Greggory Price, Ph.D., interim director of Duke University’s Center for Regenerative Neuroscience.